Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

This is a collection of current resources related to Nirsevimab.

Implications of Food and Drug Administration Approval of Respiratory Syncytial Virus Prophylactic Medication
2023 · Boston Children's Hospital, · Stony Brook Children's Hospital
This brief article discusses the implications of the FDA approval of nirsevimab, a monoclonal antibody, for preventing respiratory syncytial virus (RSV) lower respiratory tract infections …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie